User profiles for Osvaldo Espin-Garcia
 | Osvaldo Espin-GarciaEpidemiology and Biostatistics, University of Western Ontario Verified email at uwo.ca Cited by 1898 |
[HTML][HTML] Metodología para un scoring de clientes sin referencias crediticias
O Espin-García, CV Rodríguez-Caballero - Cuadernos de economía, 2013 - scielo.org.co
Las decisiones de otorgamiento de crédito son cruciales en la administración de riesgos.
Las instituciones financieras han desarrollado y usado modelos de credit scoring para …
Las instituciones financieras han desarrollado y usado modelos de credit scoring para …
Association of host genome with intestinal microbial composition in a large healthy cohort
Intestinal microbiota is known to be important in health and disease. Its composition is
influenced by both environmental and host factors. Few large-scale studies have evaluated the …
influenced by both environmental and host factors. Few large-scale studies have evaluated the …
Increased intestinal permeability is associated with later development of Crohn's disease
…, JB Meddings, L Bedrani, N Power, O Espin-Garcia… - Gastroenterology, 2020 - Elsevier
Background & Aims Increased intestinal permeability has been associated with Crohn’s
disease (CD), but it is not clear whether it is a cause or result of the disease. We performed a …
disease (CD), but it is not clear whether it is a cause or result of the disease. We performed a …
Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease
Background & Aims The gut microbiome has been suggested to play a role in gut barrier
hemostasis, but data are scarce and limited to animal studies. We therefore aimed to assess …
hemostasis, but data are scarce and limited to animal studies. We therefore aimed to assess …
Mediterranean-like dietary pattern associations with gut microbiome composition and subclinical gastrointestinal inflammation
Background & Aims Case-control studies have shown that patients with Crohn’s disease (CD)
have a microbial composition different from healthy individuals. Although the causes of …
have a microbial composition different from healthy individuals. Although the causes of …
Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics
Objective A sentinel lymph node biopsy is widely accepted as the standard of care for surgical
staging in low-grade endometrial cancer, but its value in high-grade endometrial cancer …
staging in low-grade endometrial cancer, but its value in high-grade endometrial cancer …
Gut microbiome composition is associated with future onset of Crohn's disease in healthy first-degree relatives
Background & Aims The cause of Crohn’s disease (CD) is unknown, but the current
hypothesis is that microbial or environmental factors induce gut inflammation in genetically …
hypothesis is that microbial or environmental factors induce gut inflammation in genetically …
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn's disease highlight earliest events of pathogenesis
Objective The measure of serum proteome in the preclinical state of Crohn’s disease (CD)
may provide insight into biological pathways involved in CD pathogenesis. We aimed to …
may provide insight into biological pathways involved in CD pathogenesis. We aimed to …
Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma
Background Systemic inflammatory scores may aid prognostication and patient selection for
trials. We compared five scores in advanced pancreatic adenocarcinoma (PDAC). Methods …
trials. We compared five scores in advanced pancreatic adenocarcinoma (PDAC). Methods …
[HTML][HTML] Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
We report herein an exploratory biomarker analysis of refractory tumors collected from
pediatric patients before atezolizumab therapy (iMATRIX-atezolizumab, NCT02541604 ). …
pediatric patients before atezolizumab therapy (iMATRIX-atezolizumab, NCT02541604 ). …
